Showing results (491-500 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|August 1, 1992
A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group studyT Vats, G Buchanan, P Mehta, et al.Investigational New Drugs|November 20, 2009
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumorsNeeltje Steeghs, Hans Gelderblom, Judith Wessels, et al.Investigational New Drugs|October 31, 2009
Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2Ponnuraj Nagendraprabhu, Ganapasam SudhandiranInvestigational New Drugs|October 31, 2009
Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysisMaurizio Viale, Cinzia Cordazzo, Daniela de Totero, et al.Investigational New Drugs|September 13, 2014
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicinIrene Brana, Alberto Ocana, Eric X Chen, et al.Investigational New Drugs|January 8, 2015
Chemotherapy with cytochalasin congeners in vitro and in vivo against murine modelsMatthew Trendowski, Joan M Mitchell, Christine M Corsette, et al.Investigational New Drugs|October 24, 2014
Novel benzoxazines as inhibitors of angiogenesisSara Al-Rawi, Terri Meehan-Andrews, Chris Bradley, et al.Investigational New Drugs|October 24, 2014
Preclinical combination therapy of the investigational drug NAMI-A(+) with doxorubicin for mammary cancerAlberta Bergamo, Tina Riedel, Paul J Dyson, et al.Investigational New Drugs|October 25, 2014
Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloidsMarco Mrusek, Ean-Jeong Seo, Henry Johannes Greten, et al.Investigational New Drugs|October 2, 2015
Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignanciesDiana Markozashvili, Vincent Ribrag, Yegor S VassetzkyPageof 372